Trump keeps touting a malaria drug to treat coronavirus despite a lack of clinical evidence showing that it's effective. Here's how to enroll in a clinical trial.

Crystal Cox/Business Insider

• The malaria drugs chloroquine and hydroxychloroquine have rapidly become top potential coronavirus treatments.
• But they lack any high-quality clinical evidence that shows they are effective against COVID-19.
• Dr. David Boulware, a University of Minnesota infectious disease professor, is running two experiments to test hydroxychloroquine in large controlled trials to determine the drug's effectiveness. Both are now open for enrollment.
• One study is assessing whether taking hydroxychloroquine can prevent infections in people who have recently been exposed to the virus. The other trial is seeing if taking the drug can reduce the hospitalization rate for COVID-19 patients who just started to show symptoms.
• People can now apply to enroll in both studies at trialcovid.com. The researchers are hoping to have clinical results from both studies in about a month.  
• Visit Business Insider's homepage for more stories.

An old, generic malaria drug has rapidly become a leading potential coronavirus treatment, as President Donald Trump has repeatedly touted its potential against the virus and the US government has built up a massive stockpile of the medication.

On Sunday, the US Food and Drug Administration granted an emergency authorization — the first for any COVID-19 treatment — allowing doctors to use chloroquine or hydroxychloroquine in hospitalized COVID-19 patients who cannot enroll in clinical trials. 

See the rest of the story at Business Insider

NOW WATCH: 4 potential coronavirus treatments that researchers are working on right now

See Also:

• The next wave of coronavirus outbreaks is threatening cities from New Orleans to Philadelphia, and it reveals the US is on pace for a national epidemic
• Most Americans in a new poll say they're touching their loved ones as much as they did before the coronavirus pandemic, and some are being even more intimate
• J&J just sped up the timeline for its coronavirus vaccine, and said it could be ready for emergency use early next year

from Business Insider https://ift.tt/3bIHfup